These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6531442)

  • 1. The effects of administration of meta-tyramine and para-tyramine on dopamine and its metabolites in the rat striatum.
    McQuade PS; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):705-9. PubMed ID: 6531442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of beta-phenylethylamine on tyramine and dopamine metabolism.
    McQuade PS; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):755-9. PubMed ID: 6686706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cat retina for dopamine, dihydroxyphenylacetic acid, 3-methoxytyramine and homovanillic acid.
    Vaughn DM; Lindley DM; Cox NR; Simpson ST; Whitmer WL
    Vet Res Commun; 1989; 13(3):173-81. PubMed ID: 2781720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in rat brain striatum by high-performance liquid chromatography with electrochemical detection.
    Saraswat LD; Holdiness MR; Justice JB; Salamone JD; Neill DB
    J Chromatogr; 1981 Mar; 222(3):353-62. PubMed ID: 7228945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugated dopamine in superfusates of slices of rat striatum.
    Tyce GM; Rorie DK
    J Neurochem; 1982 Nov; 39(5):1333-9. PubMed ID: 7119800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.
    Zetterström T; Sharp T; Collin AK; Ungerstedt U
    Eur J Pharmacol; 1988 Apr; 148(3):327-34. PubMed ID: 3384000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites.
    Diggory GL; Buckett WR
    Eur J Pharmacol; 1984 Oct; 105(3-4):257-63. PubMed ID: 6510470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of amfonelic acid and some other central stimulants on mouse striatal tyramine, dopamine and homovanillic acid.
    Juorio AV
    Br J Pharmacol; 1982 Nov; 77(3):511-5. PubMed ID: 7139200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
    Kwok RP; Juorio AV
    Neuroendocrinology; 1986; 43(5):590-6. PubMed ID: 3528901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats.
    Chapman CD; Gazzara RA; Howard SG
    Neuropharmacology; 1990 Apr; 29(4):319-25. PubMed ID: 2342635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F; Achilli G; Perego C; Algeri S
    Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some factors affecting striatal 3-methoxytyramine concentrations in the mouse and rat.
    McQuade PS; Richard JW; Thakur M
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):725-9. PubMed ID: 4089199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of raphé nuclei lesions on striatal tyramine concentration and dopamine turnover in the rat.
    Juorio AV; Greenshaw AJ
    Neurochem Res; 1986 May; 11(5):687-93. PubMed ID: 2425268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P
    J Pharm Pharmacol; 1987 Feb; 39(2):127-9. PubMed ID: 2881997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of dopamine release in the denervated striatum.
    Altar CA; Marien MR
    Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine.
    Wong PT; Teo WL; Lee T
    Neuroreport; 1993 Oct; 5(1):53-6. PubMed ID: 7506588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.